KPTI
Karyopharm Therapeutics Inc
0.645$
-0.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.9% | -15.0% | +4.7% | -11.5% | -13.2% | -22.3% | -17.9% | -8.2% | +12.7% | +21.2% | -15.3% | |
| – | -11.1% | -15.2% | +5.1% | -11.4% | -15.3% | -23.2% | -18.6% | -8.3% | +14.9% | +22.5% | -15.8% | |
| – | +19.6% | -41.4% | +176.8% | -14.1% | -14.2% | -37.9% | -0.1% | -2.7% | +60.7% | +50.1% | -39.5% | |
| – | -8.1% | -22.4% | +2.4% | -12.2% | -18.6% | -35.7% | -26.1% | -11.3% | +38.9% | +42.5% | -28.3% | |
| – | -28.9% | +15.3% | +22.2% | -16.4% | -3.2% | +14.6% | -6.6% | -3.2% | -17.9% | -10.8% | +27.9% | |
| – | -2.0% | -9.0% | +25.5% | +34.4% | +1.4% | +0.6% | +4.7% | -20.6% | +1.8% | -10.9% | +11.0% | |
| – | +1.7% | -0.9% | -7.3% | +0.9% | +0.4% | -4.8% | +3.1% | +6.3% | +9.8% | -1.1% | +11.2% | |
| – | +11.9% | -6.0% | -11.8% | +6.7% | +50.0% | -2.1% | +9.8% | -12.2% | +5.6% | +27.4% | +14.4% | |
| – | +3.5% | +3.5% | +3.5% | +3.5% | +577.9% | +2.1% | +26.5% | -57.4% | +60.8% | +51.3% | -96.8% | |
| – | +231.2% | +61.0% | -44.4% | +106.8% | -11.7% | +15.0% | -55.8% | +107.6% | -25.8% | +6.9% | +79.0% | |
| – | +0.1% | +0.1% | +11.7% | -0.3% | -14.5% | -5.0% | -1.7% | +16.1% | +16.5% | -6.7% | +9.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +0.6% | +33.8% | -19.0% | +0.7% | +0.9% | +1.8% | +0.6% | +110.1% | +35.7% | +17.1% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.